Recursion Pharmaceuticals Inc (RXRX) — Cash Flow Reinvestment Rate
Latest as of March 2022:
1.96x
Recursion Pharmaceuticals Inc (RXRX) has a Cash Flow Reinvestment Rate of 1.96x as of March 2022, reinvesting $151.99 Million (capex $4.34 Million plus investments $147.65 Million) from operating cash flow of $77.39 Million. Explore Recursion Pharmaceuticals Inc cash flow conversion to assess how effectively this company generates cash.
Reinvestment Rate
1.96x
(Capex + Investments) / Operating CF
Total Reinvested
$151.99 Million
Capex + Investments
Operating Cash Flow
$77.39 Million
USD
Capital Expenditures
$4.34 Million
USD
Annual Cash Flow Reinvestment Rate for Recursion Pharmaceuticals Inc (None–None)
Year-by-year capital reinvestment analysis for Recursion Pharmaceuticals Inc. For live market cap and broader valuation context, see Recursion Pharmaceuticals Inc (RXRX) total market value.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow